Director · Olema Pharmaceuticals, Inc. · Common Stock
Side
SELL
Value
$102K
Shares
3,489
Price
$29.12
Executed
Jan 14, 2026
Disclosed
Jan 16, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jan 14 executedJan 16, 2026 disclosed
OLMA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering+10 / 15
2 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Harmon Cyrus filed this Form 4 reporting a open-market sale of OLMA on Jan 14, 2026. It became public on Jan 16, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Harmon Cyruscik:0001831410
Issuer
Olema Pharmaceuticals, Inc.cik:0001750284
Revision history · 0
No field has changed since this record was first ingested.
